197 related articles for article (PubMed ID: 35146040)
1. Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant
Zasowski EJ; Trinh TD; Claeys KC; Lagnf AM; Bhatia S; Klinker KP; Veve MP; Estrada SJ; Johns ST; Sawyer AJ; Huang V; LaFrance B; Levine DP; Kaye KS; Davis SL; Rybak MJ
Open Forum Infect Dis; 2022 Mar; 9(3):ofab606. PubMed ID: 35146040
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
3. Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection.
Barlow A; Heil EL; Claeys KC
Infect Dis Ther; 2021 Mar; 10(1):605-612. PubMed ID: 33484408
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
[TBL] [Abstract][Full Text] [Related]
6. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
8. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
9. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline.
Ahmad O; Crawford TN; Myint T
Infect Dis Ther; 2020 Mar; 9(1):77-87. PubMed ID: 31776844
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
11. Early Initiation of Ceftaroline-Based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia.
Hicks AS; Dolan MA; Shah MD; Elwood SE; Platts-Mills JA; Madden GR; Elliott ZS; Eby JC
Res Sq; 2024 Mar; ():. PubMed ID: 38559201
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections.
Schweizer ML; Richardson K; Vaughan Sarrazin MS; Goto M; Livorsi DJ; Nair R; Alexander B; Beck BF; Jones MP; Puig-Asensio M; Suh D; Ohl M; Perencevich EN
Clin Infect Dis; 2021 Jan; 72(Suppl 1):S68-S73. PubMed ID: 33512521
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
Patel D; Brown ML; Edwards S; Oster RA; Stripling J
Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant
Huang C; Chen I; Lin L
Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009973
[TBL] [Abstract][Full Text] [Related]
15.
Davis KP; McDermott LA; Snydman DR; Aldridge BB
Microbiol Spectr; 2024 Jun; ():e0097624. PubMed ID: 38916355
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Werth BJ; Barber KE; Ireland CE; Rybak MJ
Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant
Alsowaida YS; Alsolami A; Almangour TA
J Chemother; 2024 Apr; ():1-6. PubMed ID: 38606836
[TBL] [Abstract][Full Text] [Related]
18. Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System.
Mootz ML; Britt RS; Mootz AA; Lee GC; Reveles KR; Evoy KE; Teng C; Frei CR
Hosp Pract (1995); 2019 Oct; 47(4):186-191. PubMed ID: 31578888
[No Abstract] [Full Text] [Related]
19. Ceftaroline and Daptomycin Combination Antibiotic Therapy for a Methicillin-Resistant
Heger ML; Al-Sayyad B
J Pediatr Pharmacol Ther; 2022; 27(8):754-759. PubMed ID: 36989005
[No Abstract] [Full Text] [Related]
20. Clinical Outcomes With Definitive Treatment of Methicillin-Resistant
Nichols CN; Wardlow LC; Coe KE; Sobhanie MME
Open Forum Infect Dis; 2021 Jul; 8(7):ofab327. PubMed ID: 34337094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
